Skip to main content
. 2019 Nov 16;8(12):931–939. doi: 10.1002/psp4.12472

Figure 5.

Figure 5

Observed and physiologically‐based pharmacokinetic (PBPK) model‐simulated concentrations of paclitaxel in tissues (a) and plasma (b) following a dose of 175 mg/m2 in patients with solid tumors. Black dots represent observed data, and solid lines and dash lines represent the mean and 90% confidence intervals of the simulations from the proposed PBPK model.